Compare ZDAI & ITOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZDAI | ITOC |
|---|---|---|
| Founded | 2022 | 1998 |
| Country | Hong Kong | China |
| Employees | N/A | 10 |
| Industry | General Bldg Contractors - Nonresidential Bldgs | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3M | 7.0M |
| IPO Year | 2024 | 2024 |
| Metric | ZDAI | ITOC |
|---|---|---|
| Price | $0.38 | $0.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 683.4K | ★ 4.0M |
| Earning Date | 02-24-2026 | 03-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $15,141,479.00 | $305,215.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.20 | $0.32 |
| 52 Week High | $1.10 | $32.00 |
| Indicator | ZDAI | ITOC |
|---|---|---|
| Relative Strength Index (RSI) | 38.44 | 29.88 |
| Support Level | $0.31 | $0.41 |
| Resistance Level | $0.75 | $0.49 |
| Average True Range (ATR) | 0.10 | 0.06 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 5.84 | 36.88 |
DirectBooking Technology Co Ltd, formerly Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
iTonic Holdings Ltd through its subsidiary, focuses on healthcare solutions for brachytherapy, a targeted radiation therapy used in cancer treatment. Its product, Beijing Feitian's Treatment Planning System, helps ensure safe and effective brachytherapy using radioactive sources inside the patient to kill cancer cells and shrink tumors.